ABSTRACT
Nipah encephalitis is a particular dangerous disease that affects animals and man. Fatal cases of the disease have been identified in the persons looking after pigs in the villages of Malaysia. The causative agent is presumably referred to as morbilliviruses of the Paramixoviridae family. Two hundred persons died among the ill patients with the signs of encephalitis. The principal hosts of the virus were fox-bats (Megaschiroptera) inhabiting in the surrounding forests. The present paper descries the epidemiological features of the disease, its clinical manifestations, abnormal anatomic changes, diagnosis, and implemented controlling measures.
Subject(s)
Disease Outbreaks , Disease Reservoirs/veterinary , Henipavirus Infections , Nipah Virus , Swine Diseases , Animals , Antibodies, Viral/blood , Chiroptera/virology , Disease Reservoirs/virology , Encephalitis, Viral/pathology , Environmental Monitoring , Epidemiological Monitoring , Henipavirus Infections/diagnosis , Henipavirus Infections/epidemiology , Henipavirus Infections/virology , Humans , Malaysia/epidemiology , Nipah Virus/classification , Nipah Virus/immunology , Nipah Virus/isolation & purification , Sus scrofa , Swine Diseases/diagnosis , Swine Diseases/epidemiology , Swine Diseases/virologyABSTRACT
The CS vaccine strain of Classical Swine Fever Virus is a derivative from the LK parental strain that has been used in Russia for more than 30 years. A 10697 nucleotide fragment of the CS strain's genome has been sequenced. Sixteen unique restriction markers have been found in the CS genome comparing to the following strains: Alfort187, Alfort Tubingen, Brescia, CAP, Glentorf, ALD, GPE-, Chinese, C-strain, Riems, P97. Fourteen of these sites (AflII, AvaI, CfoI, Eco47II, HaeII, KpnI, MunI, NspI, PstI, ScaI, SmaI, SpeI, StyI, VspI) are only present in the CS strain genome. The 2 sites (BgII, NdeI) are present in all other genomes except for the genome of vaccine strain. A PCR/restriction test has been developed based on these findings in order to distinguish the vaccine strain from field isolates. Two pairs of nested primers and a criteria of analysis have been designed for each restriction marker site. The tests have been conducted first on the reference strains resulting in predicted restriction patterns. Finally, the tests have been applied to a number of field isolates obtained at different locations in Russia in different years. These results give further evidence that PCR/restriction tests can identify the LK and CS vaccines helping to avoid confusion with field strains.
